CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 254 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $3,000 | -25.0% | 600 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $4,000 | +33.3% | 600 | 0.0% | 0.00% | +100.0% |
Q4 2020 | $3,000 | 0.0% | 600 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $3,000 | -25.0% | 600 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $4,000 | 0.0% | 600 | 0.0% | 0.00% | -33.3% |
Q1 2020 | $4,000 | -33.3% | 600 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $6,000 | +200.0% | 600 | 0.0% | 0.00% | +200.0% |
Q3 2019 | $2,000 | -77.8% | 600 | 0.0% | 0.00% | -75.0% |
Q2 2019 | $9,000 | -40.0% | 600 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $15,000 | +36.4% | 600 | 0.0% | 0.01% | +20.0% |
Q4 2018 | $11,000 | -8.3% | 600 | +50.0% | 0.01% | +25.0% |
Q3 2018 | $12,000 | -33.3% | 400 | 0.0% | 0.00% | -42.9% |
Q2 2018 | $18,000 | -14.3% | 400 | 0.0% | 0.01% | +16.7% |
Q1 2018 | $21,000 | -22.2% | 400 | 0.0% | 0.01% | -25.0% |
Q4 2017 | $27,000 | +8.0% | 400 | +33.3% | 0.01% | 0.0% |
Q3 2017 | $25,000 | – | 300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |